We herein report the case of a patient with functional ileal NET grade 2 (NET G2) and synchronous liver metastases, who received IFNα therapy after intensified SSA monotherapy and tumor debulking failed, resulting in a complete recovery from symptoms of hormone hypersecretion and a sustained tumor response of 30 months without any serious adverse events. This evidence concerns the gene IFNA1 and neoplasm.